Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1311654
Reference Type
Journal Article
Title
Specific identification of formaldehyde-mediated mutagenicity using the mouse lymphoma L5178Y TK +/- assay supplemented with formaldehyde dehydrogenase
Author(s)
Blackburn, GR; Dooley, JFI; Schreiner, CA; Mackerer, C
Year
1991
Is Peer Reviewed?
Yes
Journal
In Vitro Toxicology
ISSN:
0888-319X
Volume
4
Issue
2
Page Numbers
121-132
Language
English
URL
https://search.proquest.com/docview/48402070?accountid=171501
Exit
Abstract
Formaldehyde (HCHO) is used in the synthesis of a wide variety of industrial chemicals. In some cases, the HCHO is stoichiometrically consumed during the synthesis, and is found only at trace levels in the finished product. In other cases, the reaction is reversible, and release of active formaldehyde can occur; (e.g., certain industrial biocides exert their bacteriocidal effect by this mechanism). Products which contain or release HCHO are mutagenic in bacterial and mammalian cell mutagenicity assays. We have developed a modification to the mouse lymphoma L5178Y TK+/-assay that permits determination of whether a suspect material is inherently mutagenic or is active solely because it contains HCHO in free or latent form. The modification involves addition of the enzyme formaldehyde dehydrogenase (FDH) at a concentration of 0.09 units/ml, and its cofactor, NAD+ at 8.1 mM, during the exposure period. The addition of FDH and NAD+ eliminated the toxicity and dose-dependent increase in mutant frequency (2-18 fold) produced by HCHO in both the nonactivated and S-9 activated assays. Toxicity and mutagenicity of HCHO-releasing species present as contaminants in a polymeric coating and as the active agent in industrial biocides was similarly reduced or eliminated. Mutagenicity unrelated to HCHO was unaffected by the modification. This modified assay can be used to identify HCHO-mediated mutagensis from compounds for which hydrolytic or enymatic release of HCHO can occur.
Keywords
ANIMALS; CYTOLOGY; HISTOCYTOCHEMISTRY; GENETICS; CYTOGENETICS; ANIMALS/GENETICS; BIOCHEMISTRY; AMINO ACIDS; PEPTIDES; PROTEINS; POISONING; ANIMALS, LABORATORY; CELL LINE; NEOPLASMS/PATHOLOGY; CARCINOGENS; HERBICIDES; PEST CONTROL; PESTICIDES; MURIDAE; Cytology and Cytochemistry-Animal; Genetics and Cytogenetics-General; Genetics and Cytogenetics-Animal; Biochemical Studies-General; Biochemical Studies-Proteins; Toxicology-General; Neoplasms and Neoplastic Agents-Neoplastic Cell Lines; Neoplasms and Neoplastic Agents-Carcinogens and Carcinogenesis; 50-00-0
Tags
IRIS
•
Formaldehyde [archived]
Prior to 2013 Search
Human Cancer Studies
Found
Screened
Not Relevant
Not Epi
Genotoxicity
Cited in text
Retroactive RIS import
Pre2013
HCHO 2013 Cancer Epi (2017 Criteria)
Formaldehyde IRIS 2011
Old references
•
IRIS Formaldehyde (Inhalation) [Final 2024]
Literature Indexing
Other sources and cited references
Literature Identification
Cancer in Humans
Excluded
Mechanistic Studies of Respiratory Tract Cancer, Genotoxicity
Met Peco
Mechanistic Studies of Lymphohematopoietic Cancer, Genotoxicity
Supplemental or not primary research
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity